top of page
  • Benjamí

Fulbright and EMBO fund collaboration with Baker lab

Benjamí has spent a 3-month sabbatical in David Baker's lab, a world-reference in protein design, to establish collaborations on conditionally-activated biotherapeutics and new systems for drug transport into the brain.

90 visualizaciones0 comentarios

Entradas Recientes

Ver todo

Chemical & Synthetic Biology
for Biotherapies

Challenging Brain Diseases

ChemSynBio logo 29102023_transparente.png
bottom of page